Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 155-163
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.155
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.155
Figure 5 Vasoactive intestinal peptide in human plasma.
Vasoactive intestinal peptide (VIP) protein levels were not significantly different in IBS patients (n = 12, 0.193 ng/mL) when compared to controls (n = 11, 0.254 ng/mL), P = 0.173. IBS: Irritable bowel syndrome.
- Citation: Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1): 155-163
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/155.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.155